A glucagon-like peptide-1 receptor antagonist reduces the insulin response to a glycemic meal in ponies
Journal of Animal Science · 2023
DOI: 10.1093/jas/skad389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Animal Science, 2023. Verfasst von Melody A de Laat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science, Queensland University of Technology, Brisbane, QLD, Australia. Hauptthemen laut MEDLINE: Hyperinsulinism, Horse Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
High plasma concentrations of insulin can cause acute laminitis. Ponies and horses with insulin dysregulation (ID) exhibit marked hyperinsulinemia in response to dietary hydrolyzable carbohydrates. Glucagon-like peptide-1 (GLP-1), an incretin hormone released from the gastrointestinal tract, enhances insulin release, and is increased postprandially in ponies with ID. The aim of this study was to determine whether blocking the GLP-1 receptor reduces the insulin response to a high glycemic meal. Five adult ponies were adapted to a cereal meal and then given two feed challenges 24 h apart of a meal containing 3 g/kg BW micronized maize. Using a randomized cross-over design all ponies received both treatments, where one of the feeds was preceded by the IV administration of a GLP-1 receptor blocking peptide, Exendin-3 (9-39) amide (80 µg/kg), and the other feed by a sham treatment of peptide diluent only. Blood samples were taken before feeding and peptide administration, and then at 30-min intervals via a jugular catheter for 6 h for the measurement of insulin, glucose, and active GLP-1. The peptide and meal challenge caused no adverse effects, and the change in plasma glucose in response to the meal was not affected (P = 0.36) by treatment: peak concentration 9.24 ± 1.22 and 9.14 ± 1.08 mmol/L without and with the antagonist, respectively. Similarly, there was no effect (P = 0.35) on plasma active GLP-1 concentrations: peak concentration 14.3 ± 1.36 pM and 13.7 ± 1.97 pM without and with the antagonist, respectively. However, the antagonist caused a significant decrease in the area under the curve for insulin (P = 0.04), and weak evidence (P = 0.06) of a reduction in peak insulin concentration (456 ± 147 μIU/mL and 370 ± 146 μIU/mL without and with the antagonist, respectively). The lower overall insulin response to the maize meal after treatment with the antagonist demonstrates that blocking the GLP-1 receptor partially reduced insulin production in response to a high starch, high glycemic index, diet. Using a different methodological approach to published studies, this study also confirmed that GLP-1 does contribute to the excessive insulin production in ponies with ID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Science, Queensland University of Technology, Brisbane, QLD, Australia.
- Equine Studies Group, Waltham Petcare Science Institute, Melton Mowbray, UK.
- Melbourne Veterinary School, The University of Melbourne, Parkville, VIC, Australia.
ORCID-Profile: Melody A de Laat
Zitieren
APA
de Laat, M. A., Fitzgerald, D. M., Harris, P. A., & Bailey, S. R. (2023). A glucagon-like peptide-1 receptor antagonist reduces the insulin response to a glycemic meal in ponies. Journal of Animal Science. https://doi.org/10.1093/jas/skad389
Vancouver
de Laat MA, Fitzgerald DM, Harris PA, Bailey SR. A glucagon-like peptide-1 receptor antagonist reduces the insulin response to a glycemic meal in ponies. Journal of Animal Science. 2023. doi:10.1093/jas/skad389
BibTeX
@article{deLaat2023,
author = {de Laat, Melody A and Fitzgerald, Danielle M and Harris, Patricia A and Bailey, Simon R},
title = {A glucagon-like peptide-1 receptor antagonist reduces the insulin response to a glycemic meal in ponies},
journal = {Journal of Animal Science},
year = {2023},
doi = {10.1093/jas/skad389}
}
EUVIMED